D. Delmas, A. Lancon, D. Colin, B. Jannin, and N. Latruffe, Resveratrol as a chemopreventive agent: a promising molecule for fighting cancer, Curr Drug Targets, vol.7, pp.423-442, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00376282

R. Nakata, S. Takahashi, and H. Inoue, Recent advances in the study on resveratrol, Biol Pharm Bull, vol.35, pp.273-279, 2012.

J. Tome-carneiro, M. Gonzalvez, M. Larrosa, M. J. Yanez-gascon, F. J. Garcia-almagro et al., Resveratrol in primary and secondary prevention of cardiovascular disease: a dietary and clinical perspective, Ann N Y Acad Sci, vol.1290, pp.37-51, 2013.

J. A. Baur, K. J. Pearson, N. L. Price, H. A. Jamieson, C. Lerin et al., Resveratrol improves health and survival of mice on a high-calorie diet, Nature, vol.444, pp.337-342, 2006.

M. Lagouge, C. Argmann, Z. Gerhart-hines, H. Meziane, C. Lerin et al., Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha, Cell, vol.127, pp.1109-1122, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00188005

V. W. Dolinsky, K. E. Jones, R. S. Sidhu, M. Haykowsky, M. P. Czubryt et al., Improvements in skeletal muscle strength and cardiac function induced by resveratrol during exercise training contribute to enhanced exercise performance in rats, J Physiol, vol.590, pp.2783-2799, 2012.

E. Tauriainen, M. Luostarinen, E. Martonen, P. Finckenberg, M. Kovalainen et al., Distinct effects of calorie restriction and resveratrol on diet-induced obesity and fatty liver formation, J Nutr Metab, p.525094, 2011.

J. Mercader, A. Palou, and M. L. Bonet, Resveratrol enhances fatty acid oxidation capacity and reduces resistin and retinol-binding protein 4 expression in white adipocytes, J Nutr Biochem, vol.22, pp.828-834, 2011.

S. J. Park, F. Ahmad, A. Philp, K. Baar, T. Williams et al., Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases, Cell, vol.148, pp.421-433, 2012.

N. L. Price, A. P. Gomes, A. J. Ling, F. V. Duarte, A. Martin-montalvo et al., SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function, Cell Metab, vol.15, pp.675-690, 2012.

N. Gregersen, B. S. Andresen, C. B. Pedersen, R. K. Olsen, T. J. Corydon et al., Mitochondrial fatty acid oxidation defects-remaining challenges, J Inherit Metab Dis, vol.31, pp.643-657, 2008.

S. E. Olpin, Pathophysiology of fatty acid oxidation disorders and resultant phenotypic variability, J Inherit Metab Dis, vol.36, pp.645-658, 2013.

J. P. Bonnefont, F. Djouadi, C. Prip-buus, S. Gobin, A. Munnich et al., Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects, Mol Aspects Med, vol.25, pp.495-520, 2004.

S. Gobin-limballe, F. Djouadi, F. Aubey, S. Olpin, B. S. Andresen et al., Genetic basis for correction of very-long-chain acyl-coenzyme A dehydrogenase deficiency by bezafibrate in patient fibroblasts: toward a genotype-based therapy, Am J Hum Genet, vol.81, pp.1133-1143, 2007.
URL : https://hal.archives-ouvertes.fr/inserm-02896262

J. P. Bonnefont, J. Bastin, P. Laforet, F. Aubey, A. Mogenet et al., Long-term follow-up of bezafibrate treatment in patients with the myopathic form of carnitine palmitoyltransferase 2 deficiency, Clin Pharmacol Ther, vol.88, pp.101-108, 2010.
URL : https://hal.archives-ouvertes.fr/inserm-02896226

F. Djouadi and J. Bastin, PPARs as therapeutic targets for correction of inborn mitochondrial fatty acid oxidation disorders, J Inherit Metab Dis, vol.31, pp.217-225, 2008.
URL : https://hal.archives-ouvertes.fr/inserm-02896250

J. Bastin, A. Lopes-costa, and F. Djouadi, Exposure to resveratrol triggers pharmacological correction of fatty acid utilization in human fatty acid oxidation-deficient fibroblasts, Hum Mol Genet, vol.20, pp.2048-2057, 2011.
URL : https://hal.archives-ouvertes.fr/inserm-02894854

K. R. Patel, E. Scott, V. A. Brown, A. J. Gescher, W. P. Steward et al., Clinical trials of resveratrol. Ann N Y Acad Sci, vol.1215, pp.161-169, 2011.

C. H. Cottart, V. Nivet-antoine, C. Laguillier-morizot, and J. L. Beaudeux, Resveratrol bioavailability and toxicity in humans, Mol Nutr Food Res, vol.54, pp.7-16, 2010.

T. Walle, Bioavailability of resveratrol, Ann N Y Acad Sci, vol.1215, pp.9-15, 2011.

J. Hoshino, E. J. Park, T. P. Kondratyuk, L. Marler, J. M. Pezzuto et al., Selective synthesis and biological evaluation of sulfate-conjugated resveratrol metabolites, J Med Chem, vol.53, pp.5033-5043, 2010.

D. Delmas and H. Y. Lin, Role of membrane dynamics processes and exogenous molecules in cellular resveratrol uptake: consequences in bioavailability and activities, Mol Nutr Food Res, vol.55, pp.1142-1153, 2011.

A. Lancon, D. Delmas, H. Osman, J. P. Thenot, B. Jannin et al., Human hepatic cell uptake of resveratrol: involvement of both passive diffusion and carrier-mediated process, Biochem Biophys Res Commun, vol.316, pp.1132-1137, 2004.

B. Calamini, K. Ratia, M. G. Malkowski, M. Cuendet, J. M. Pezzuto et al., Pleiotropic mechanisms facilitated by resveratrol and its metabolites, Biochem J, vol.429, pp.273-282, 2010.

F. Djouadi, J. P. Bonnefont, L. Thuillier, V. Droin, N. Khadom et al., Correction of fatty acid oxidation in carnitine palmitoyl transferase 2-deficient cultured skin fibroblasts by bezafibrate, Pediatr Res, vol.54, pp.446-451, 2003.
URL : https://hal.archives-ouvertes.fr/inserm-02896299

F. Djouadi, F. Aubey, D. Schlemmer, J. P. Ruiter, R. J. Wanders et al., Bezafibrate increases very-long-chain acyl-CoA dehydrogenase protein and mRNA expression in deficient fibroblasts and is a potential therapy for fatty acid oxidation disorders, Hum Mol Genet, vol.14, pp.2695-2703, 2005.
URL : https://hal.archives-ouvertes.fr/inserm-02896287

D. J. Boocock, K. R. Patel, G. E. Faust, D. P. Normolle, T. H. Marczylo et al., Quantitation of trans-resveratrol and detection of its metabolites in human plasma and urine by high performance liquid chromatography, J Chromatogr B Analyt Technol Biomed Life Sci, vol.848, pp.182-187, 2007.

R. Zamora-ros, C. Andres-lacueva, R. M. Lamuela-raventos, T. Berenguer, P. Jakszyn et al., Concentrations of resveratrol and derivatives in foods and estimation of dietary intake in a Spanish population: European prospective investigation into cancer and nutrition (EPIC)-Spain cohort, Br J Nutr, vol.100, pp.188-196, 2008.

D. Kang, S. H. Kim, and N. Hamasaki, Mitochondrial transcription factor A (TFAM): roles in maintenance of mtDNA and cellular functions, Mitochondrion, vol.7, pp.39-44, 2007.

A. Lancon, N. Hanet, B. Jannin, D. Delmas, J. M. Heydel et al., Resveratrol in human hepatoma HepG2 cells: metabolism and inducibility of detoxifying enzymes, Drug Metab Dispos, vol.35, pp.699-703, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00259260

C. Gotz, R. Pfeiffer, J. Tigges, V. Blatz, C. Jackh et al., Xenobiotic metabolism capacities of human skin in comparison with a 3D epidermis model and keratinocyte-based cell culture as in vitro alternatives for chemical testing: activating enzymes (Phase I), Exp Dermatol, vol.21, pp.358-363, 2012.

C. Gotz, R. Pfeiffer, J. Tigges, K. Ruwiedel, U. Hubenthal et al., Xenobiotic metabolism capacities of human skin in comparison with a 3D-epidermis model and keratinocyte-based cell culture as in vitro alternatives for chemical testing: phase II enzymes, Exp Dermatol, vol.21, pp.364-369, 2012.

F. Oesch, E. Fabian, B. Oesch-bartlomowicz, C. Werner, and R. Landsiedel, Drugmetabolizing enzymes in the skin of man, rat, and pig, Drug Metab Rev, vol.39, pp.659-698, 2007.

A. M. Sharma and J. Uetrecht, Bioactivation of drugs in the skin: relationship to cutaneous adverse drug reactions, Drug Metab Rev, 2013.

P. Bourassa, C. D. Kanakis, P. Tarantilis, M. G. Pollissiou, and H. A. Tajmir-riahi, Resveratrol, genistein, and curcumin bind bovine serum albumin, J Phys Chem B, vol.114, pp.3348-3354, 2010.

T. P. Kondratyuk, E. J. Park, L. E. Marler, S. Ahn, Y. Yuan et al., Resveratrol derivatives as promising chemopreventive agents with improved potency and selectivity, Mol Nutr Food Res, vol.55, pp.1249-1265, 2011.

S. Rimbaud, M. Ruiz, J. Piquereau, P. Mateo, D. Fortin et al., Resveratrol improves survival, hemodynamics and energetics in a rat model of hypertension leading to heart failure, PLoS One, vol.6, p.26391, 2011.
URL : https://hal.archives-ouvertes.fr/inserm-00651075

S. Timmers, E. Konings, L. Bilet, R. H. Houtkooper, T. Van-de-weijer et al., Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans, Cell Metab, vol.14, pp.612-622, 2011.

K. J. Menzies, K. Singh, A. Saleem, and D. A. Hood, Sirtuin 1-mediated effects of exercise and resveratrol on mitochondrial biogenesis, J Biol Chem, vol.288, pp.6968-6979, 2013.

A. Csiszar, N. Labinskyy, J. T. Pinto, P. Ballabh, H. Zhang et al., Resveratrol induces mitochondrial biogenesis in endothelial cells, Am J Physiol Heart Circ Physiol, vol.297, pp.13-20, 2009.

L. Costa, A. , L. Bachelier, C. Mathieu, L. Rotig et al., Beneficial effects of resveratrol on respiratory chain defects in patients' fibroblasts involve estrogen receptor and estrogen-related receptor alpha signaling, Hum Mol Genet, vol.23, pp.2106-2119, 2014.
URL : https://hal.archives-ouvertes.fr/inserm-02894840

R. K. Olsen, N. Cornelius, and N. Gregersen, Genetic and cellular modifiers of oxidative stress: what can we learn from fatty acid oxidation defects?, Mol Genet Metab, vol.110, pp.31-39, 2013.

. Aires, Stilbenes and resveratrol metabolites improve mitochondrial fatty acid oxidation defects in human fibroblasts, Orphanet Journal of Rare Diseases, vol.9, p.79, 2014.
URL : https://hal.archives-ouvertes.fr/inserm-02896233